Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Emerging resistance to fluoroquinolones in staphylococci: an alert.

× No keyword cloud information.

30 in total

Review 1. Pharmacoeconomics of selective decontamination of the digestive tract in intensive care patients: a US perspective.

Authors: S J Markowsky; J Christie
Journal: Pharmacoeconomics Date: 1994-05 Impact factor: 4.981

2. Active efflux as a mechanism of resistance to ciprofloxacin in Streptococcus pneumoniae.

Authors: V Zeller; C Janoir; M D Kitzis; L Gutmann; N J Moreau
Journal: Antimicrob Agents Chemother Date: 1997-09 Impact factor: 5.191

3. Antibacterial activities of nemonoxacin against clinical isolates of Staphylococcus aureus: an in vitro comparison with three fluoroquinolones.

Authors: Zhaoxia Li; Youning Liu; Rui Wang; Aimin Li
Journal: World J Microbiol Biotechnol Date: 2014-08-18 Impact factor: 3.312

4. Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center.

Authors: W V Kern; E Andriof; M Oethinger; P Kern; J Hacker; R Marre
Journal: Antimicrob Agents Chemother Date: 1994-04 Impact factor: 5.191

5. Prospective evaluation of a two-week course of intravenous antibiotics in intravenous drug addicts with infective endocarditis. Grupo de Estudio de Enfermedades Infecciosas de la Provincia de Cádiz.

Authors: M Torres-Tortosa; M de Cueto; A Vergara; A Sánchez-Porto; E Pérez-Guzmán; M González-Serrano; J Canueto
Journal: Eur J Clin Microbiol Infect Dis Date: 1994-07 Impact factor: 3.267

6. Acute bacterial diarrhoea in the emergency room: therapeutic implications of stool culture results.

Authors: N Kaminski; V Bogomolski; R Stalnikowicz
Journal: J Accid Emerg Med Date: 1994-09

7. Quinolone resistance mutations in topoisomerase IV: relationship to the flqA locus and genetic evidence that topoisomerase IV is the primary target and DNA gyrase is the secondary target of fluoroquinolones in Staphylococcus aureus.

Authors: E Y Ng; M Trucksis; D C Hooper
Journal: Antimicrob Agents Chemother Date: 1996-08 Impact factor: 5.191

8. Opportunities to Improve Fluoroquinolone Prescribing in the United States for Adult Ambulatory Care Visits.

Authors: Sarah Kabbani; Adam L Hersh; Daniel J Shapiro; Katherine E Fleming-Dutra; Andrew T Pavia; Lauri A Hicks
Journal: Clin Infect Dis Date: 2018-06-18 Impact factor: 9.079

9. [Classification and microbiology of osteomyelitis].

Authors: W Zimmerli; U Flückiger
Journal: Orthopade Date: 2004-03 Impact factor: 1.087

10. Examination of methicillin-resistant and methicillin-susceptible Staphylococcus aureus mutants with low-level fluoroquinolone resistance.

Authors: M C Sulavik; N L Barg
Journal: Antimicrob Agents Chemother Date: 1998-12 Impact factor: 5.191